Evidence map›Paper›PMID 19763325›Full record

ReviewMolecular bioSystems2009

Scoring overlapping and adjacent signals from genome-wide ChIP and DamID assays.

Audrey Qiuyan Fu, Boris Adryan

Abstract readReview
In one paragraph

Review in Molecular bioSystems, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Audrey Qiuyan FuCambridge Systems Biology Centre, University of Cambridge, Tennis Court Road, Cambridge, UK. qf205@cam.ac.uk
Boris Adryan

Funding

Biotechnology and Biological Sciences Research Council BB/F00897X/1Wellcome Trust 087522
6 · The paper itself

Abstract

Much of the research utilising genome-wide ChIP and DamID assays aims to understand the combinatorial feature of transcription factor binding and the chromatin modification code. With these experimental methods becoming more affordable and widespread, the focus of research is shifting to making sense of the data. Amongst the many challenges arising from data analyses, we are concerned with identifying biologically meaningful co-occurrences of transcription factor binding or chromatin modifications, using genome-wide profiles generated from ChIP and DamID assays. Co-occurrences are reflected in overlapping and adjacent signals in multiple ChIP or DamID profiles. We review existing quantitative methods to score overlaps and to cluster binding events in ChIP and DamID profiles. For pairwise comparison, existing methods either are based on a single score at the genome level or take a genomic, region-specific view. To draw inference from many profiles simultaneously, methods exist to cluster regions by their regulatory importance or to infer cis-regulatory modules for a particular region. We provide a simple guide to some of the statistical tools used by these methods.

Indexed as

GenomeSignal Processing, Computer-AssistedChromatin ImmunoprecipitationComputational BiologyGenetic TechniquesOligonucleotide Array Sequence AnalysisRegulatory Sequences, Nucleic AcidSite-Specific DNA-Methyltransferase (Adenine-Specific)Transcription FactorsSite-Specific DNA-Methyltransferase (Adenine-Specific)Transcription Factors

Identifiers

PMID19763325
PMCPMC3475982

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.